Biotechnology

Researchers Celebrate Breakthrough in Cancer Treatment

Published in Cancer Weekly, February 2nd, 1998

Years of research into safer and more potent cancer treatments may have begun to pay off with advances that use the body's own defenses.

Biotechnology companies gathered at the Hambrecht and Quist Healthcare Conference, held in San Diego, California, during January 1998 to discuss progress in bringing new drugs to market say some of their most promising research involves monoclonal antibodies, which are natural immune system chemicals that have been altered for use as cancer drugs.

Because they originate in the human body, they are far less toxic than chemotherapy and radiation, and several companies are steaming ahead to develop therapies based on...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry